Sciences

Sources scientifiques pour le contenu et les procédures médicales dans la DiGA medidux™

Les sources suivantes ont été utilisées pour le contenu médical et les procédures dans notre DiGA :

• Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol. 2016 Feb 20;34(6):557-65. doi: 10.1200/JCO.2015.63.0830.
  
  
• Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156. PMID: 28586821; PMCID: PMC5817466.
  
  
• Egbring M, Far E, Roos M, Dietrich M, Brauchbar M, Kullak-Ublick GA, Trojan A. A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial. J Med Internet Res. 2016 Sep 6;18(9):e238. doi: 10.2196/jmir.6414. PMID: 27601354; PMCID: PMC5030453
  
  
• Margulies A, Kroner T, Gaisser A, Bachmann-Mettler I. Onkologische Krankenpflege. 6. Edition. Springer Berlin, Heidelberg. 2017 June 09. doi: 10.1007/978-3-662-53955-2.
  
  
• Pircher M, Winder T, Trojan A. Response to vemurafenib in metastatic triple-negative breast cancer harbouring a BRAF V600E mutation: a case report and electronically captured patient-reported outcome. Case Rep Oncology. 2021, Feb
  
  
• Trojan A, Bättig B, Mannhart M, Seifert B, Brauchbar MN, Egbring M. Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study. JMIR Cancer 2021;7(1):e26950. doi: 10.2196/26950. PMID: 33729162. PMCID: 8088839
  
  
• Trojan A, Leuthold N, Thomssen C, Rody A, Winder T, Jakob A, Egger C, Held U, Jackisch CJ. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial. Med Internet Res. 2021 Aug 5;23(8):e29271. doi: 10.2196/29271.
  
  
• National Cancer Institute. Common Terminology Criteria for Adverse Events v.4.0 (CTCAE). Available at: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Accessed March 8th, 2017.

Sélection d’études récentes avec notre DiGA:

• OGIPRO (NCT5234021)
• CARTePRO (NCT05354973)
• PRO2 (NCT05425550)
• ECOVAR (NCT05352217)
• SwissCanOn (BASEC-Nr. 2021-02519)
• PRO (NCT03578731)